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Each year, the American Cancer Society (ACS) publishes
a report summarizing its recommendations for early
cancer detection, data and trends in cancer screening
rates, and selected issues related to cancer screening.
For endometrial cancer
The ACS recommends that women at very high risk for
endometrial cancer due to 1) known HNPCC genetic
mutation carrier status; 2) a substantial likelihood of
being a mutation carrier (ie, a mutation is known to be
present in the family); or 3) the absence of genetic
testing results in families with a suspected autosomal
dominant predisposition to colon cancer should con-
sider beginning annual testing for the detection of early
endometrial cancer at age 35 years.
For cervical cancer
Screening for cervical cancer should begin approximately
3 years after first vaginal intercourse, but no later than
age 21 years. Until age 30 years, women at average risk
should receive either annual screening with conventional
cervical cytology smears or biennial screening using
liquid-based cytology. After age 30 years, a woman who
has had 3 consecutive technically satisfactory Papanico-
laou (Pap) tests with normal/negative results may choose
to either undergo screening every 2 to 3 years.
For ovarian cancer
The guidelines recommend that women at average and
increased risk should be informed about the high
genetic risk. High-risk family histories with an elevated
risk of developing ovarian cancer include >2 breast
cancers and 1 or more cases of ovarian cancer at any
age, >3 cases of breast cancer before age 50 years, sister
pairs with cancers less than age 50 years, cases of breast
cancer occurring at or before age 40 years. Preventive
Surgery ( bilateral salpingo-oophorectomy ) can reduce
risk of ovarian and fallopian tube cancers for BRCA1,
BRCA2 carriers and might improve survival rates in
women carrying the BRCA1 or BRCA2 genes by about
half a year to over two years.
For vulvar cancer
The guidelines recommend that women at average and
increased risk should be informed about the risk factors:
the majority of women diagnosed with vulvar cancer are
older than 50. However, a significant percentage (15%) of
women under 40 develop vulvar cancer. Generally, vulvar
cancer in younger women is associated with HPV infec-
tion and smoking; women with lowered immune systems
have a higher risk of developing vulvar cancer; about 4%
of women with lichen sclerosus develop vulvar cancer.
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